Cell Culture Derived Recombinant HBsAg is Highly Immunogenic and Protects Chimpanzees from Infection with Hepatitis B Virus
- 1 July 1986
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 4 (7), 630-636
- https://doi.org/10.1038/nbt0786-630
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements.Journal of Clinical Investigation, 1984
- In Vitro Response to HBsAg of Peripheral Blood Lymphocytes from Recipients of Hepatitis B VaccineHepatology, 1984
- Reduction in Risk of Hepatitis Transmission by Heat-Treatment of a Human Factor VIII ConcentrateThe Journal of Infectious Diseases, 1984
- Human hepatitis B vaccine from recombinant yeastNature, 1984
- Interference between non‐a, non‐b and hepatitis b virus infection in chimpanzeesJournal of Medical Virology, 1983
- Antigenicity and immunogenicity of hepatitis B virus particles produced by mouse cells transfected with cloned viral DNAVirology, 1982
- Synthesis and assembly of hepatitis B virus surface antigen particles in yeastNature, 1982
- Direct Expression of Hepatitis B Surface Antigen in Monkey Cells from an SV40 VectorDNA, 1982
- A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final reportHepatology, 1981
- Type B Hepatitis: A Review of Current Prospects for a Safe and Effective VaccineClinical Infectious Diseases, 1980